Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

33%(1 trials)

Terminated

1(25%)

Phase Distribution

Ph phase_4

25%

Ph phase_1

25%

Ph phase_3

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

Phase 3Large-scale testing

2(50.0%)

Phase 4Post-market surveillance

1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Detailed Status

Completed3

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (25.0%)

Phase 32 (50.0%)

Phase 41 (25.0%)

Trials by Status

terminated125%

completed375%

Recent Activity

0 active trials

Showing 4 of 4

completedphase_1

The Impact of Obesity and Obesity Treatments on Breast Cancer

NCT00933309

completedphase_3

Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)

NCT00131664

terminatedphase_4

Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study

NCT00343395

completedphase_3

AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes

NCT00359112

Clinical Trials (4)

Showing 4 of 4 trials

NCT00933309Phase 1

The Impact of Obesity and Obesity Treatments on Breast Cancer

Completed

NCT00131664Phase 3

Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)

Completed

NCT00343395Phase 4

Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study

Terminated

NCT00359112Phase 3

AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4